Zacks Investment Research upgraded shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) from a hold rating to a buy rating in a research note released on Monday, Zacks.com reports. The firm currently has $27.00 price objective on the stock. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research […]
Related Keywords
United States , Denmark , Copenhagen , Køavn , America , Rexulti Rxulti , Brintellix Trintellix , Abilify Maintena , Jpmorgan Chase Co , Credit Suisse Group , Zacks Investment Research , Barclays , Get Rating , Suisse Group , North America , H Lundbecka S , Otcmkts Hluyy , Hluyy , Medical , Upgrade ,
comparemela.com © 2020. All Rights Reserved.